- Nov 12, 2004
- 1,665
- 0
- 0
Update Dec 26 '07
Yahoo! news link, AFP
:thumbsup:
*******************************************************************
Link to my original AT P&N posting on this news piece
AP Science News article link on Yahoo!
I like the fact that this news article does not throw softballs to anyone on any side of this issue. Research takes a long, long time to develop into actual treatments. Sometimes, it yields no results. And this research may be the same. But the fact of the matter is that federal money should only be available to ethical research. Money talks, and if there is no money in embryonic stem cell research, then the demand for embryos will be low, and hopefully the both legal and illegal production of embryos will be "stemmed" in favor of for example fertilization clinics which follow strict ethical guidelines and only fertilize embryos which will be implanted.
***********************************
UPDATE Dec 6 '07 further down page
***********************************
Yahoo! news link, AFP
2007 stem cell breakthrough is like turning lead into gold
by Mira Oberman, AFP
Wed Dec 26, 5:10 PM ET
CHICAGO (AFP) - It was the kind of breakthrough scientists had dreamed of for decades and its promise to help cure disease appears to be fast on the way to being realized.
Researchers in November announced they were able to turn the clock back on skin cells and transform them into stem cells, the mutable building blocks of organs and tissues.
Then just earlier this month a different team announced it had cured sickle cell anemia in mice using stem cells derived from adult mouse skin.
"This is truly the Holy Grail: To be able to take a few cells from a patient -- say a cheek swab or few skin cells -- and turn them into stem cells in the laboratory," said Robert Lanza, a stem cell pioneer at Advanced Cell Technology.
"This work represents a tremendous scientific milestone - the biological equivalent of the Wright Brothers' first airplane," he told AFP.
"It's bit like learning how to turn lead into gold."
Stem cells offer enormous potential for curing and treating disease because they can be transformed into any cell in the body and then hopefully used to replace damaged or diseased cells, tissues and organs.
But stem cell research has been highly controversial because -- until now -- viable embryos had to be destroyed to extract the stem cells.
US President George W. Bush has banned all federal funding for research on human embryonic stem cells and access to stem cells in other countries has also been restricted because of the difficulty in finding women willing to donate their eggs.
The new technique, while far from perfected, is so promising that the man who managed to clone the world's first sheep, Dolly, is giving up his work cloning embryos to focus on studying stem cells derived from skin cells.
"The fact that (the) introduction of a small number of proteins into adult human cells could produce cells that are equivalent to embryo stem cells takes us into an entirely new era of stem cell biology," said Ian Wilmut, the Scottish researcher who first created a viable clone by transferring a cell nucleus into a new embryo.
One of the greatest advantages of the new technique is its simplicity: it takes just four genes to turn the skin cell back into a stem cell.
This, unlike the complex and expensive process developed by Wilmut, can be done in a standard biological lab. And skin cells are much easier to harvest than embryos.
"It's an explosion of resources," said Konrad Hochedlinger, of the Harvard Stem Cell Institute.
Prior to this discovery, researchers who wanted to look at how diseases developed would usually have to study animals or organs harvested from cadavers because embryonic stem cells were so hard to use and access.
But with stem cells derived from skin, tissues and organs can be grown in a petri dish, making it easier for researchers to map the genetic structure of diseased cells, a process which could unlock a cure.
They could also allow researchers to do chemical screens to identify drugs which may cure or treat a disease, a process which could significantly speed up the process of bringing life-saving drugs to the market.
The use of skin cells will eventually allow doctors to create stem cells with a specific patient's genetic code, eliminating the risk that the body would reject transplanted tissues or organs.
Researchers have already shown this is possible when they cured sickle cell anemia in mice.
They used skin cells taken from the tails of sick mice, transformed them into stem cells, manipulated those stem cells into healthy bone marrow cells and then transplanted them into the sick mice.
And since the new cells came from the sick mice, there was also no need for dangerous immunosuppressant drugs to prevent rejection.
:thumbsup:
*******************************************************************
Link to my original AT P&N posting on this news piece
AP Science News article link on Yahoo!
For example, the inspiration for a group of cystic fibrosis drugs now being tested in people or animals goes back 18 years to a genetic discovery. And more generally, gene therapy ? the notion of fixing or replacing defective genes ? has been studied in people for more than 15 years without much success.
At least, federal money for research into the new kind of cell won't be a problem, said Story Landis, head of the National Institutes of Health's Stem Cell Task Force. The task force is about to invite scientists to apply for new grants for such work, she said.
This week's advance has apparently solved a supply problem for the study of embryonic stem cells. These cells are valued for their ability to morph into any of the cell types of the body. Scientists had long searched for a way to produce embryonic cells that carry the genes of a particular person.
Such cells could be used for at least three purposes. The most highly publicized one is to create transplant tissue for treating disease. In the shorter term, they could be used to create "diseases in a dish," colonies of cells bearing illness-promoting genes that could reveal the vulnerable roots of medical conditions. And finally, scientists could use such cells for rapidly screening potential medicines in the laboratory.
Until this week's announcement, scientists who wanted to make such cells looked to an expensive, cumbersome cloning process that destroyed embryos, making it an ethical lightning rod. And it hadn't yet worked with human embryos.
The new technique is much simpler. It makes human skin cells behave like embryonic stem cells without using embryos at all.
End of problem? Not unless these altered skin cells can truly replace embryonic cells, and that's not clear yet, a prominent scientist says.
Paul Berg, a Stanford University Nobel laureate who helped establish federal guidelines for human research on genetically manipulated cells, said the celebration over this week's announcement is premature.
"I'm amazed at the ethicists" saying the problem of needing embryos has been solved, Berg said. "We're not in the clear ? this is a first step."
I like the fact that this news article does not throw softballs to anyone on any side of this issue. Research takes a long, long time to develop into actual treatments. Sometimes, it yields no results. And this research may be the same. But the fact of the matter is that federal money should only be available to ethical research. Money talks, and if there is no money in embryonic stem cell research, then the demand for embryos will be low, and hopefully the both legal and illegal production of embryos will be "stemmed" in favor of for example fertilization clinics which follow strict ethical guidelines and only fertilize embryos which will be implanted.
***********************************
UPDATE Dec 6 '07 further down page
***********************************